title: Association of L-arginine transporters with fodrin: implications for hypoxic inhibition of arginine uptake.
abstract: In this study, we investigated the possible interaction between the cationic amino acid transporter (CAT)-1 arginine transporter and ankyrin or fodrin. Because ankyrin and fodrin are substrates for calpain and because hypoxia increases calpain expression and activity in pulmonary artery endothelial cells (PAEC), we also studied the effect of hypoxia on ankyrin, fodrin, and CAT-1 contents in PAEC. Exposure to long-term hypoxia (24 h) inhibited L-arginine uptake by PAEC, and this inhibition was prevented by calpain inhibitor 1. The effects of hypoxia and calpain inhibitor 1 were not associated with changes in CAT-1 transporter content in PAEC plasma membranes. However, hypoxia stimulated the hydrolysis of ankyrin and fodrin in PAEC, and this could be prevented by calpain inhibitor 1. Incubation of solubilized plasma membrane proteins with anti-fodrin antibodies resulted in a 70% depletion of CAT-1 immunoreactivity and in a 60% decrease in L-arginine transport activity in reconstituted proteoliposomes (3,291 +/- 117 vs. 8,101 +/- 481 pmol. mg protein(-1). 3 min(-1) in control). Incubation with anti-ankyrin antibodies had no effect on CAT-1 content or L-arginine transport in reconstituted proteoliposomes. These results demonstrate that CAT-1 arginine transporters in PAEC are associated with fodrin, but not with ankyrin, and that long-term hypoxia decreases L-arginine transport by a calpain-mediated mechanism that may involve fodrin proteolysis.
authors.affiliation: Research Service, Malcom Randall Department of Veterans Affairs Medical Center, and Department of Medicine, University of Florida, Gainesville, Florida 32608-1197, USA.
authors.forename: S I
authors.initials: SI
authors.lastname: Zharikov
authors.forename: E R
authors.initials: ER
authors.lastname: Block
mesh_terms: D026923:Amino Acid Transport Systems, Basic; D000818:Animals; D017487:Ankyrins / Q000378:metabolism; D001120:Arginine / Q000037:antagonists & inhibitors* / Q000378:metabolism; D002154:Calpain / Q000037:antagonists & inhibitors; D002352:Carrier Proteins / Q000378:metabolism*; D002462:Cell Membrane / Q000378:metabolism; D046508:Culture Techniques; D015853:Cysteine Proteinase Inhibitors / Q000494:pharmacology; D004730:Endothelium, Vascular / Q000378:metabolism / Q000473:pathology; D006023:Glycoproteins / Q000494:pharmacology; D000860:Hypoxia / Q000378:metabolism*; D015151:Immunoblotting; D008565:Membrane Proteins / Q000378:metabolism*; D008840:Microfilament Proteins / Q000378:metabolism*; D011233:Precipitin Tests; D011651:Pulmonary Artery / Q000378:metabolism / Q000473:pathology; D012016:Reference Values; D013552:Swine; D013049:Spectrin
chemical_list: D026923:Amino Acid Transport Systems, Basic; D017487:Ankyrins; D001120:Arginine; D002154:Calpain; D002352:Carrier Proteins; D015853:Cysteine Proteinase Inhibitors; D006023:Glycoproteins; D008565:Membrane Proteins; D008840:Microfilament Proteins; D013049:Spectrin; C039304:calpain inhibitors